Chlordiazepoxide is indicated for the short-term (2–4 weeks) treatment of anxiety that is severe and disabling or subjecting the person to unacceptable distress. Reference standards of Chlordiazepoxide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
2-Amino-5-chlorobenzophenone
Catalogue No.:PA 03 40030
CAS :
Molecular Formula : C13H10ClNO
Molecular Weight : 231.68
Desoxochlordiazepoxide
Catalogue No.:PA 03 0401000
Molecular Formula : C16H14ClN3
Molecular Weight : 283.76
N-Nitrosochlordiazepoxide
Catalogue No.:PA 03 0401001
Molecular Formula : C16H13ClN4O2
Molecular Weight : 328.76
8-Chloro-N-methyl-9b-phenyl-3,9b-dihydrobenzo[f][1,2]oxazireno[2,3-d][1,4]diazepin-4-amine
Catalogue No.:PA 03 0401002
Molecular Formula : C16H14ClN3O
Molecular Weight : 299.76
7-Chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide
Catalogue No.:PA 03 40010
Molecular Formula : C15H11ClN2O2
Molecular Weight : 286.71
6-Chloro-2-(chloromethyl)-4-phenylquinazoline 3-oxide
Catalogue No.:PA 03 40020
Molecular Formula : C15H10Cl2N2O
Molecular Weight : 305.16
Chlordiazepoxide Impurity A (IMPC066)
Catalogue No.:PA IMPC066
Molecular Formula : NA
Molecular Weight : NA
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
